List of insiders holdings for Apellis Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Morningside Venture Investments Ltd 10% Owner |
2022-02-14 16:05:11 | 12,806,342 0 |
12,806,342 | Form 13G |
| 2 | Potentia Holdings LLC 10% Owner |
2018-02-07 18:59:55 | 3,826,601 0 |
3,826,601 | Form 13G |
| 3 | Cormorant Asset Management LLC Chen Bihua Cormorant Global Healthcare GP LLC Cormorant Global Healthcare Master Fund LP 10% Owner |
2020-02-14 16:07:26 | 2,700,000 0 |
2,700,000 | Form 13G |
| 4 | Cormorant Asset Management LLC Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Chen Bihua 10% Owner |
2020-02-14 16:07:26 | 2,700,000 0 |
2,700,000 | Form 13G |
| 5 | AJU IB Investment Co. Ltd. 10% Owner |
2017-11-13 16:29:47 | 0 2,292,062 |
2,292,062 | Form 4 |
| 6 | Hillhouse Capital Management Ltd. 10% Owner |
2019-02-14 15:15:04 | 2,098,581 0 |
2,098,581 | Form 13G |
| 7 | Francois Cedric Chief Executive Officer |
2025-01-30 12:03:08 | 415,695 1,539,422 |
1,955,117 | Form 4 |
| 8 | venBio Global Strategic Fund II L.P. 10% Owner |
2019-02-14 08:50:47 | 1,790,102 0 |
1,790,102 | Form 13G |
| 9 | Deschatelets Pascal Chief Scientific Officer |
2025-01-30 12:07:31 | 1,147,716 0 |
1,147,716 | Form 4 |
| 10 | GELLERT MICHAEL E 10% Owner |
2017-11-13 16:25:54 | 943,989 0 |
943,989 | Form 4 |
| 11 | Machiels Alec Director |
2025-01-03 16:23:44 | 388,227 411,950 |
800,177 | Form 4 |
| 12 | Axon Steven Chief Business Officer |
2018-11-15 20:40:03 | 398,499 0 |
398,499 | Form 4 |
| 13 | Dunlop A. Sinclair Director |
2025-01-03 16:17:32 | 169,592 100,000 |
269,592 | Form 4 |
| 14 | Watson David O. General Counsel |
2025-03-06 17:17:05 | 138,730 80,136 |
218,866 | Form 4 |
| 15 | Sullivan Timothy Eugene Chief Financial Officer |
2025-01-30 12:15:46 | 128,665 70,396 |
199,061 | Form 4 |
| 16 | SCHEIBLER LUKAS Chief Research Officer |
2023-12-05 19:40:46 | 107,690 0 |
107,690 | Form 4 |
| 17 | Grossi Federico Chief Medical Officer |
2023-01-09 19:02:36 | 94,884 0 |
94,884 | Form 4 |
| 18 | Baumal Caroline Chief Medical Officer |
2025-01-21 15:54:49 | 93,301 0 |
93,301 | Form 4 |
| 19 | Townsend Adam J. Chief Commercial Officer |
2025-01-30 12:18:22 | 84,050 0 |
84,050 | Form 4 |
| 20 | DeLong Mark Jeffrey Chief Business & Strat Officer |
2025-02-12 13:59:21 | 83,945 0 |
83,945 | Form 4 |
| 21 | Nicholson Nur Chief Technical Officer |
2025-01-30 12:13:56 | 83,664 0 |
83,664 | Form 4 |
| 22 | Lewis Karen Chief People Officer |
2025-01-30 12:12:03 | 70,251 0 |
70,251 | Form 4 |
| 23 | Eisele Jeffrey Chief Development Officer |
2025-01-30 12:10:43 | 55,312 0 |
55,312 | Form 4 |
| 24 | Chopas James George VP/Chief Accounting Officer |
2025-03-18 12:27:02 | 47,955 0 |
47,955 | Form 4 |
| 25 | Celona Lucia See Remarks |
2020-02-12 16:58:26 | 36,488 0 |
36,488 | Form 4 |
| 26 | FONTEYNE PAUL R. Director |
2025-01-03 16:19:39 | 33,904 0 |
33,904 | Form 4 |
| 27 | O'Brien Stephanie Monaghan Director |
2025-01-03 16:25:24 | 28,904 0 |
28,904 | Form 4 |
| 28 | Chan Gerald Director |
2025-01-03 16:12:41 | 28,904 0 |
28,904 | Form 4 |
| 29 | Walbert Keli Director |
2025-01-10 17:39:26 | 24,478 0 |
24,478 | Form 4 |
| 30 | Lackner Thomas A. See Remarks |
2020-02-12 16:50:35 | 24,075 0 |
24,075 | Form 4 |
| 31 | Brown Victoria L. Program Team Lead |
2023-01-24 16:57:32 | 23,556 0 |
23,556 | Form 4 |
| 32 | Sadr Ahmad See Remarks |
2020-02-12 16:46:30 | 19,075 0 |
19,075 | Form 4 |
| 33 | Perry Nicole D Vice President - Accounting |
2021-08-03 16:23:59 | 11,008 0 |
11,008 | Form 4 |